CA 19.9 proves accurate diagnostic for bladder cancer
This article was originally published in Clinica
Executive Summary
Measuring CA 19.9 is a "reliable, non-invasive, and inexpensive screening technique" for diagnosing early bladder cancer in high-risk patients, such as those with schistosomiasis, say researchers from cancer institutes in Cairo (Egypt) and Graz (Austria). Bladder cancer accounts for 26.4% of total cancer incidence in Egypt.